S. GHERARDELLI, G. BERSANI - Vol. 6, Giugno 2000, num.2
Testo Immagini Bibliografia Summary Riassunto Indice
"Neurological Soft Signs" e variabili
cliniche nella schizofrenia
"Neurological Soft Signs" and clinical
variables in schizophrenia
S. GHERARDELLI, G. BERSANI
III Clinica Psichiatrica,
Università di Roma "La Sapienza"
1 Kraepelin E.
Dementia praecox and paraphrenia.
Huntington: NY Krieger 1919.
2 Bleuler E.
Dementia praecox or the group of schizophrenias.
New York: International University Press 1911.
3 Bender L, Fink N, Green M.
Childhood schizophrenia: clinical study of one hundred schizophrenic children.
Am J Orthopsychiatry 1947;17:40-6.
4 Kennard MA.
Value of equivocal signs in neurologic diagnosis.
Neurol 1960;10:753-64.
5 Shapiro T, Burkes L, Petti TA, Ranz J.
Consistency of non focal neurological signs.
J Am Acad Child Psychiatry 1978;17:70-9.
6 Quitkin F, Rifkin A, Klein DF.
Neurological soft signs in schizophrenia and character disorders. Organicity
in schizophrenia with premorbid asociality and emotionality unstable character
disorders.
Arch Gen Psychiatry 1976;33:845-53.
7 Owens DGC, Johnstone EC.
Spontaneus involuntary disorders of movements: their prevalence, severity
and distribution in chronic schizophrenics with and without treatment with
neuroleptics.
Arch Gen Psychiatry 1982;39:452-61.
8 Rogers D.
Motor disorders in psychiatry.
Chichester: John Wiley 1992.
9 Buchanan RW, Heinrichs DW.
The Neurological Evaluation Scale (NES): a structured instrument for assessment
of neurological signs in schizophrenia.
Psychiatry Res 1989;27:335-50.
10 De Cataldo S, Rossi A, Di Michele V, Manna V, Bolino
F, Casacchia M.
Neurological soft signs in schizofrenia.Riv Psichiatria 1990;25:1-6.
11 Rochford MD, Detre MD, Tucker GJ, Harrow M.
Neuropsychological impairments in functional psychiatric disease.
Arch Gen Psychiatry 1970;22:114-8.
12 Mosher LR, Pollin W, Stabenau JR.
Identical twins discordant for schizophrenia.
Arch Gen Psychiatry 1971;24:422-30.
13 Tucker GJ, Silberrfarb PM.
Neurologic dysfunction in schizophrenia: significance for diagnostic practice.
In: Akiskal HS, Webb WL, eds. Psychiatric diagnosis: exploration of
biological predictors. New York: Spectrum 1978:453-62.
14 Walker E, Green M.
Soft signs of neurological dysfunction in schizophrenia: an investigation
of lateral performance.
Biol Psychiatry 1982;17:381-6.
15 Heinrichs DW, Buchanan RW.
Significance and meaning of neurological soft signs in schizophrenia.
Am J Psychiatry 1988;145:11-8.
16 Kinney DK, Woods BT, Yurgelun-Todd D.
Neurologic abnormalities in schizophrenic patients and their families:
II neurologic and psychiatric findings in relatives.
Arch Gen Psychiatry 1986;43:665-8.
17 Rossi A, De Cataldo S, Di Michele V, Manna V, Cessoli
S, Stratta P, et al.
Neurological soft signs in schizophrenia.
Br J Psychiatry 1990;157:735-9.
18 Rieder RO, Nichols PL.
Offspring of schizophrenics III. Hyperactivity and neurological soft signs.
Arch Gen Psychiatry 1979;36:665-74.
19 McNeil TF, Kaij L.
Obstetric factors in the development of schizophrenia: complications in
the births of preschizophrenics and in reproduction in schizophrenic
parents.
In: Wynne LC, Cromwell RL, eds. The nature of schizophrenia. New
York: John Wiley and Sons 1978:401-29.
20 Diagnostic criteria from DSM IV TM.
I edizione. Washington DC: American Psychiatric Association 1994.
21 Woods BT, Kinney DK, Yurgelun-Todd D.
Neurological abnormalities in schizophrenic patients and their family.
I: Comparison of schizophrenic, bipolar, and substance abuse patients and
normal controls.
Arch Gen Psychiatry 1986;43:657-63.
22 Simpson GM, Angus JWS.
Drug induced extrapiramidal disorders.
Acta Psychiatr Scand 1970;(suppl.)212:1-58.
23 Lund CE, Mortimer AM, Rogers D, McKenna PJ.
Motor volitional and behavioural disorders in schizophrenia: assessment
using the modified Rogers scale.
Br J Psychiatry 1991;158:323-7.
24 Nucifora D, Calandra C.
Segni neurologici minori ed aprassie nella schizofrenia.
Minerva Psichiatr 1997;38:55-66.
25 Merriam AE, Kay SR, Opler LA, Kushner SF, Praag HM.
Neurological signs and the positive-negative dimension in schizophrenia.
Biol Psychiatry 1990;28:181-92.
26 Schröder J, Neithammer R, Geider FJ, Reitz C,
Blinkert M, Jauss M, et al.
Neurological soft signs in schizophrenia.
Schizophr Res 1992b;6:25-30.
27 Chen EYH, Shapleske J, Luque R, McKenna PJ, Hodges
JR, Calloway SP, et al.
The Cambridge neurological inventory: a clinical instrument for assessment
of soft neurological signs in psychiatric patients.
Psychiatry Res 1995;56:183-204.
28 Convit A, Volavka J, Czobor P, de Asis J, Evangelista
C.
Effect of subtle neurological dysfunction on response to haloperidol treatment
in schizophrenia.
Am J Psychiatry 1994;151:49-56.
29 Mohr F, Hubmann W, Cohen R, Bender W, Haslacher C,
Hinicke S, et al.
Neurological soft signs in schizophrenia: assessment and correlates.
Eur Arch Psychiatry Clin Neurosci 1996;246:240-8.
30 Sanders RD, Keshavan MS.
The neurologic examination in adult psychiatry: from soft signs to hard
science.
J Neuropsychiatry Clin Neurosci 1998;10:395-404.
31 Smith RC, Kadewary R.
Neurological soft signs and response to risperidone in chronic schizophrenia.
Biol Psychiatry 1996;40:1056-9.
32 Karper L, Grillon C, Lysaker P.
Soft signs, attention, and startle in schizophrenia.
Abstract in New Res Abstr. Washington DC: American Psychiatry Association
1994:358.
33 Sanders RD, Keshavan MS, Schooler NR.
Neurological examination abnormalities in neuroleptic-naive patients with
first-break schizophrenia: preliminary results.
Am J Psychiatry 1994;151:1231-3.
34 Sanders RD, Forman SD, Keshvan M.
Test-retest stability of the neurologic examination in schizophrenia
Abstract in Biol Psychiatry 1996;39:548.
35 Sanders RD, Forman ST, Pierri JN, Baker RW, Kelley
ME, Van Kammen DP, et al.
Inter-rater reliability of the neurological examination in schizophrenia.
Schizophr Res 1998;29:287-92.
36 Schlenker R, Cohen R, Berg P, Humbann W, Mohr F, Watzl
H, et al.
Smooth pursuit eye movement dysfuction in schizophrenia: the role of attention
and general psychomotor dysfuction.
Eur Arch Psychiatry Clin Neurosci 1994;244:153-60.
37 Smith RC, Hussain MI, Chowdhury SA, Stearns A.
Stability of neurological soft signs in chronically hospitalized schizophrenic
patients.
J Neuropsychiatry Clin Neurosci 1999;11:91-6.
38 Malla AK, Norman RMG, Aguilar O.
Relationship between neurological "soft signs" and syndromes
of schizophrenia.
Acta Psychiatr Scand 1997;96:274-80.
39 Dimond SSJ, Scammel RE, Pryce JG.
Callosal transfer and left-hand anomia in schizophrenia.
Biol Psychiatry 1979;14:735-9.
40 Torrey EF.
Neurological abnormalities in schizophrenic patients.
Biol Psychiatry 1980;15:381-8.
41 Tucker GJ, Campion EW, Silberfarb PM.
Sensorimotor functions and cognitive disturbance in psychiatric patients.
Am J Psychiatry 1975;132:17-21.
42 Cox SM, Ludwing AM.
Neurological soft signs and psychopathology: incidence in diagnostic
group.
Can J Psychiatry 1979;24:668-73.
43 Cox SM, Ludwing AM.
Neurological soft signs and psychopathology: findings in schizophrenia.
J Nerv Ment Dis 1979;167:161-5.
44 Nasrallah H.
Neurological differences between paranoid and non paranoid schizophrenia:
neurological soft signs.
J Clin Psychiatry 1982;43:310-2.
45 Nasrallah H.
Neurodevelopmental pathogenesis of schizophrenia.
Psychiatr Clin North Am 1993;16:269-80.
46 King DJ, Wilson A, Cooper SJ, Waddington JL.
The clinical correlates of neurological soft signs in chronic schizophrenia.
Br J Psychiatry 1991;158:770-5.
47 Manschreck TC, Maher BA, Rucklos ME.
Deficient motor synchrony in schizophrenia.
J Abnorm Psychol 1981;90:321-8.
48 Wong AHC, Voruganti LNP, Helsegrave RJ, Awad AG.
Neurocognitive deficits and neurological signs in schizophrenia.
Schizophr Res 1997;23:139-46.
49 Saykin AJ, Shtasel DL, Gur RE, Kester DB, Mozley LH,
Stafiniak P, et al.
Neuropsychological deficits in neuroleptic naive patients with first-episode
schizophrenia.
Arch Gen Psychiatry 1994;51:124-31.
50 Gupta S, Rajaprabhakaran R, Arndt S, Flaum M, Andreasen
NC.
Premorbid adjustment as a predictor of phenomenological and neurobiological
indices in schizophrenia.
Schizophr Res 1995b;16:189-97.
51 Johnstone EC, Crow TJ, Frith CD, Stevens M, Kreel L,
Husband J.
The dementia of dementia praecox.
Acta Psichiatr Scand 1978;57:305-24.
52 Crow TJ.
Molecular pathology of schizophrenia. More than one disease process?
Br Med J 1980;280:66-8.
53 Crow TJ.
Two syndromes in schizophrenia: neurochemical and structural changes.
Preatti del XXXVI Congresso Nazionale della Società Italiana di
Psichiatria. Milano 1985;1:12-4.
54 Crow TJ.
The two syndrome concept: origin and current status.
Schizophr Bull 1985;11:471-85.
55 Andreasen NC, Dennert JW, Olsen A, Damasio AR.
Hemisferic asymmetry and schizophrenia.
Am J Psychiatry 1982;139:427-30.
56 Andreasen NC, Swayze V, Flaum M, Yates WR, Arnett S,
McChesney C.
Ventricular enlargement in schizophrenia: relationship to positive or negative
symptoms.
Am J Psychiatry 1982;139:297-301.
57 Buchanan RW, Koeppl P, Brier A.
Stability of neurological signs with clozapine treatment.
Biol Psychiatry 1994;36:198-200.
58 Scheffer R, Correnti E, Borison R.
Temporal stability of neurological soft signs in first-episode psychotic
patients.
Abstr Biol Psychiatry 1994;35:715.
59 Walker E, Shaye J.
Familial schizophrenia: a predictor of neuromotor and attentional abnormalities
in schizophrenia.
Arch Gen Psychiatry 1982;39:1152-6.
60 Kolakowska T, Williams AO, Jambor K, Arden M.
Schizophrenia with good and poor outcome: early clinical features response
to neuroleptics and signs of organic disfuction
Br J Psychiatry 1985;146:229-46.
61 Kolakowska T, Williams AO, Jambor K, Arden M.
Schizophrenia with good and poor outcome: neurological soft signs, cognitive
impairment and their clinical significance.
Br J Psychiatry 1985;146:348-57.
62 Kinney DK, Yurgelun-Todd D, Woods BT.
Hard neurologic signs and psychopatology in relatives of schizophrenic
patients.
Psychiatry Res 1991;39:45-53.
63 Woods BT, Yurgelun-Todd D, Kinney DK.
Relathionship of neurological abnormalities in schizophrenics to family
psychopathology.
Biol Psychiatry 1987;21:325-31.
64 Ismail B, Cantor-Graae E, McNeil TF.
Neurological abnormalities in schizophrenic patients and their siblings.
Am J Psychiatry 1998;155:84-9.
65 Marcus J, Hans SL, Mednick SA, Schulsinger F, Michelsen
N.
Neurological dysfunctioning in offspring of schizophrenics in Israel and
Denmark.
Arch Gen Psychiatry 1985;42:753-61.
66 Cantor-Graee E, McNeill TF, Rickler KC, Sjöström
K, Rawling R, Higgins ES, et al.
Are neurological abnormalities in well discordant monozygotic co-twins
of schizophrenic subjects the result of perinatal trauma?
Am J Psychiatry 1994;151:1194-9.
67 Ismail B, Cantor-Graae E, Cardenal S, McNeil TF.
Neurological abnormalities in schizophrenia: clinical, etiological and
demographic correlates.
Schizophr Res 1998;30:229-38.
68 Prechtl HFR.
Neurological sequelae of prenatal and perinatal complications.
Br Med J 1967;4:763-7.
69 Hertzing ME.
Neurological soft signs in low-birthweight children.
Dev Med Child Neurol 1981;23:778-91.
70 Taylor DJ, Howie PW, Davidson J, Davidson D, Drillien
CM.
Do pregnancy complications contribute to neurodevelopmental disability?
Lancet 1985;1:713-6.
71 Hadders-Algra AM, Touwen BC, Huisjes HJ.
Neurologically deviant newborns: neurological and behavioural development
at the age of six years.
Dev Med Child Neurol 1986;28:569-78.
72 McNeil TF, Harty B, Blennow G, Cantor-Graae E.
Neuromotor deviation in offspring of psychotic mothers: a selective developmental
deficiency in two groups of children at heightened psychiatric risk?
J Psychiatry Res 1993;27:39-54.
73 Lane A, Colgar K, Moynihan F, Burke T, Waddington JL,
Larkin C, et al.
Schizophrenia and neurological soft signs: gender differences in clinical
correlates and antecedent factors.
Psychiatry Res 1996;64:105-114.
74 O’Callaghan E, Gibson T, Colohan H, Buckley P, Walshe
DG, Larkin C, et al.
Risk of schizophrenia in adults born after obstetric complications, and
their association with early onset of illness: a controlled study.
Br Med J 1992;305:1256-9.
75 Manschreck TC, Ames D.
Neurologic features and psychopathology in schizophrenic disorders.
Biol Psychiatry 1984;19:703-19.
76 Buchanan RW, Kirkpatrick B, Heinrichs DW, Carpenter
WT.
Clinical correlates of the deficit syndrome of schizophrenia.
Am J Psychiatry 1990;147:290-4.
77 Flashman LA, Brookshire RJ, Shwartz JAJ, Bulter SA,
Purcell DW, Caudle JM, et al.
The relationship between neurological soft signs, gender and neuropsychological
factor scores in schizophrenia.
Schizophr Res 1993;9:173-4.
78 Flashman LA, Flaum M, Gupta S, Andreasen NC.
Soft signs and neuropsychological performance in schizophrenia.
Am J Psychiatry 1996;153:526-32.
79 Chen EYH, Lam LCW, Chen RYL, Nguyen DGH.
Neurological signs, age and illness duration in schizophrenia.
J Nerv Ment Dis 1996;184:339-45.
80 Hertzing ME, Birch HG.
Neurologic organization in psychiatrically disturbed adolescents.
Arch Gen Psychiatry 1986;19:528-37.
81 Hertzing ME.
Neurologic Evaluation Schedule, in soft neurological signs.
New York: Tupper DE, eds. Grune and Straton 1987:355-68.
82 De Lisi LE, Dauphinias ID, Hanser P.
Gender differences in the brain: are they relevant to the pathogenesis
of schizophrenia?
Compr Psychiatry 1989;30:197-208.
83 Castle DJ, Murray RM.
The neurodevelopmental basis of sex differences in schizophrenia.
Psychol Med 1991;21:565-75.
84 Obiols JE, Serrano F, Caparros B, Subira S,
Barrantes N.
Neurological soft signs in adolescents with poor performance on the continous
performance test: markers of liability for schizophrenia spectrum disorders?
Psychiatry Res 1999;86:217-28.
85 Chen EYH, Lam LCW, Chen RYL, Nguyen DGH.
Negative symptoms, neurological signs and neuropsychological impairments
in 204 Hong Kong Chinese patients with schizophrenia.
Br J Psychiatry 1996;168:227-33.
86 Merriam AE, Kay SR, Opler LA, Kushner SF, Praag HM.
Neurological signs and the positive-negative dimension in schizophrenia.
Biol Psychiatry 1990;28:181-92.
87 Gherardelli S, Peronti M, Bersani G.
Associazione tra segni neurologici sfumati (neurological soft signs) e
parametri epidemiologici in pazienti schizofrenici.
Abstract in Congresso della Società Italiana di Psichiatria Biologica
1998:233.
88 Stevens JR.
Neurology and neuropathology of schizophrenia.
In: Henn FA, Nasrallah HA, eds. Schizophrenia as a brain disease.
New York: Oxford University Press 1982:112-47.
89 Weinberg DR, Wyatt RJ.
Cerebral ventricular size: a biological marker for sub-typing chronic
schizophrenia, in a biologic markers in psychiatry and neurology.
In: Ustin E, Nanin J, eds. Biological markers in psychiatry and neurology.
New York: Pergamon Press 1982.
90 Woods BT, Short MP.
Neurological dimensions of psychiatry.
Biol Psychiatry 1985;20:192-8.
91 Williams AO, Reveley MA, Kolakowska T.
Schizophrenia with good and poor outcome. II Cerebral ventricular size
and its clinical significance.
Br J Psychiatry 1985;146:239-46.
92 Sabatini U, Chollet F, Rascol O.
Effect of side and rate of stimulation on cerebral blood flow changes in
motor areas during finger movements in humans.
J Cereb Blood Flow Metab 1993;13:639-45.
93 Gunther W, Brodie JD, Bartlett EL, Dewey SL, Henn FA,
Volkow ND, et al.
Diminished cerebral metabolic response to motor stimulation in schizophrenics:
a PET study.
Eur Arch Psychiatry Clin Neurosci 1994;244:115-25.
94 Schröder J, Wenz F, Schad LR.
Sensorimotor cortex and supplementary motor area changes in schizophrenia.
A study with functional magnetic resonance imaging.
Br J Psychiatry 1995;167:197-201.
95 Schröder J, Buchsbaum MS, Siegel BV, Niethammer
R.
Structural and functional correlates of subsyndromes in chronic schizophrenia.
Psychopathol 1995;28:38-45.
96 Schröder J, Essing M, Baudendistel K, Jahn T,
Gerdsen I, Stockert, et al.
Motor dysfunction and sensorimotor cortex activation changes in schizophrenia:
a study with the functional magnetic resonance imaging.
Neuroimage 1999;9:81-7.
97 Mattay V, Callicot J, Bertolino A, Santha A, Tallent
K, Frank J, et al.
Sensorimotor cortex lateralization is anomalous in patients with schizophrenia:
a whole brain fMRI study.
Neuroimage 1997;5:S23.
98 Kim SG, Ashe J, Hendrich K.
Functional magnetic resonance imaging of motor cortex: hemispheric asymmetry
and handedness.
Sci 1993:615-8.
99 Gunther W, Petsch R, Steinberg R, Moser E, Streck P,
Heller H, et al.
Brain dysfuction during motor activation and corpus callosum alterations
in schizophrenia measured by cerebral blood flow and magnetic resonance imaging.
Biol Psychiatry 1991;29:535-55.
100 Buckley PF, Friedman L, Wu D, Lai S, Meltzer HY, Haacke
EM, et al.
Functional magnetic resonance imaging in schizophrenia: initial methology
and evaluation of motor cortex.
Psychiatry Res Neuroimaging 1997;74:13-24.
101 Liddle PF.
Schizophrenic syndromes, cognitive performance and neurological dysfunction.
Psychol Med 1987;17:49-57.
102 Overall JE, Gorham DR.
The Brief Psychiatric Rating Scale.
Psychol Rep 1962;10:799-812.
103 Liddle PF.
The symptoms of chronic schizophrenia: a re-examination of the positive-negative
dichotomy.
Br J Psychiatry 1987;151:145-51.
104 Malla AK, Norman RMG, Williamson P, Cortese L, Diaz
JF.
Three-syndrome concept of schizophrenia: a factor analytic study.
Schizophr Res 1993;10:143-50.
105 Buchanan RW,
Domains of psychopathology: an approach to the reduction of eterogeneity
in schizophrenia.
J Nerv Ment Dis 1994;182:193-204.
106 Schröder J.
Subsyndromes in chronic schizophrenia. The heterogeniety of schizophrenic
psychoses.
Fortschr Neurol Psychiatry 1998;66:15-31.
107 Goldberg TE, Torrey ES, Gold JM, Ragland JE, Bigelon
LC, Weinberger DR.
Learning and memory in monozygotic discordant for schizophrenia.
Psychol Med 1993;23:71-85.
108 Martin P, Tewesmeier M, Albers M, Schmid GB, Scharfetter
C.
Towards an understanding of sensory soft signs of schizophrenia.
Psychopathol 1995;28:281-4.
109 Schröder J, Tittel A, Stockert A, Karr M.
Memory deficits in subsyndromes of chronic schizophrenia.
Schizophr Res 1996;21:19-26.
110 Calev A, Berlin H, Lerer B.
Remote and recent memory in long-hospitalized chronic schizophrenics.
Biol Psychiatry 1987;22:79-85.
111 Owens DGC, Johnstone EC.
The disabillities of chronic schizophrenia their nature and the factors
contributing to their development.
Br J Psychiatry 1980;136:384-95.
112 Luria AR.
Higher Cortical Functions in Man.
New York. Basic books 1966.
113 Johnstone EC, Macmillan JF, Frith CD, Benn DK, Crow
TJ.
Further investigation on the predictors of outcome following first schizophrenic
episodes.
Br J Psychiatry 1990;157:182-9.
114 Mortimer AM, McKenna PJ, Lund CE.
Rating of negative symptoms using the Hight Royds Evaluation of Negativity
(HEN) Scale.
Br J Psychiatry 1989;155(suppl).7:89-91.
115 Buchanan RW, Holstein C, Breier A.
The comparative efficacy and long-term effect of clozapine treatment on
neuropsychological test performance.
Biol Psychiatry 1994;36:717-25.
116 Andreasen NC, Gupta S, Arndt S, Flaum M, Schultz SK,
Hubbard WC, et al.
Neurological soft signs in neuroleptic-naive and neuroleptic treated schizophrenic
patients and in normal comparison subject.
Am J Psychiatry 1995a;152:191-6.
117 Wolff AL, O’Driscoll GA.
Motor deficits and schizophrenia: the evidence from neuroleptic-naive patients
and population at risk.
J Psychiatry Neurosci 1999;24:304-14.